HOME
市場調査レポート
動物用ワクチンの世界市場：動物別、疾病別2022年予測
Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022
- 出版元：MarketsandMarkets
出版元について - 発行年：2017年11月
- 定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文 158ページになります。
- 商品コード：MAM845
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
動物用ワクチンの世界市場規模は2017年の推定65億ドルから、今後2022年には86億6000万ドル市場へと成長が見込まれます。家畜およびコンパニオンアニマルの飼育数増加、繰り返される家畜疾病の流行、新型ワクチンの導入などは、同市場の支持要因と言えるでしょう。
当レポートでは、2022年に至る動物用ワクチンの世界市場予測(市場規模US$)、動物タイプ別市場(豚用ワクチ、家禽用ワクチン、家畜用ワクチン、コンパニオンアニマル用ワクチン、水産養殖用ワクチン、その他)、疾病別市場(豚各種、家禽各種、家畜各種、コンパニオンアニマル各種、水産養殖各種)、技術別市場(弱毒生ワクチン、不活化ワクチン、トキソイドワクチン、組換えワクチン、その他)、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業15社プロフィール動向などの情報も交えて、動物用ワクチン市場の現在と今後展開を予測分析していきます。
【レポート構成概要】
◆ 動物用ワクチンの世界市場予測2015-2022年
・市場規模(US$)
◆ 動物タイプ別、市場-2022年
豚用ワクチン
家禽用ワクチン
家畜用ワクチン
・牛用ワクチン
・小型反芻動物ワクチン
コンパニオンアニマル用ワクチン
・犬用ワクチン
・猫用ワクチン
水産養殖用ワクチン
その他動物ワクチン
※（市場規模US$）
◆ 疾病別、市場-2022年
豚用ワクチン
・豚サーコウイルス2型(PCV2)
・豚繁殖-呼吸障害症候群(PRRS)
・豚パルボウイルス感染症
・豚インフルエンザ
・豚肺炎
・その他
家禽用ワクチン
・鶏伝染性気管支炎
・鳥インフルエンザ
・ニューカッスル病
・コクシジウム症
・伝染性ファブリキウス囊病(IBD)
・その他
家畜用ワクチン
・牛用ワクチン
-口蹄疫
-牛ウイルス性下痢感染症
-牛クロストリジウム感染症
-ブルセラ症
-牛伝染性鼻気管炎
・小型反芻動物用ワクチン
-小型反芻動物クロストリジウム感染症
-口感染症
-肺炎、敗血症
-ポックス感染症
-羊ヨーネ病
-その他
コンパニオンアニマル用ワクチン
・犬用ワクチン
-犬狂犬病
-犬ジステンパー
-犬パルボウイルス
-その他
・猫用ワクチン
-猫狂犬病
-猫ウイルス性鼻気管炎
-猫汎白血球減少症
-その他
水産養殖用ワクチン
・ビブリオ症
・パスツレラ症
・フルンケル
・その他
※（市場規模US$）
◆ 技術別、市場-2022年
・弱毒生ワクチン
・不活化ワクチン
・トキソイドワクチン
・組換えワクチン
・その他ワクチン
※（市場規模US$）
◆主要国地域別市場-2022年
欧州
北米
・米国、カナダ
アジア太平洋
・中国、タイ、インド
・その他アジア太平洋
その他地域
※ 地域別に動物タイプ別、疾病別(豚、家禽、牛用のみ)のセグメントの細分化データ掲載、詳細は目次参照
※（市場規模US$）
◆市場分析
・市場ダイナミクス（ドライバー、障壁、機会、課題）
・競合状況
◆ 動物用ワクチンの主要企業プロフィール動向
・ZOETIS
・MERCK ANIMAL HEALTH
・BOEHRINGER INGELHEIM
・ELANCO
・CEVA
・VIRBAC
・VETOQUINOL
・PHIBRO ANIMAL HEALTH
・HESTER
・HIPRA
・IDT BIOLOGIKA
・BIOGENESIS BAGO
・TIANJIN RINGPU
・CHINA ANIMAL HUSBANDRY
・JINYU BIO-TECHNOLOGY
（全158頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
英文詳細目次(table of contents)
【原文詳細目次】
Veterinary/Animal Vaccines Market by Type (Porcine, Poultry, Companion Animal, Aquaculture), Disease (Porcine Parvovirus, Swine Pneumonia, Avian Influenza, Rabies, Clostridial Diseases), Technology (Inactivated, Toxoid, Recombinant) - Global Forecast to 2022
Table of Contents
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY DATA 18
2.1.2.1 Key data from primary sources 19
2.1.2.2 Breakdown of primary interviews 19
2.1.2.3 Key industry insights 20
2.2 MARKET SIZE ESTIMATION 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.3.1 RESEARCH ASSUMPTIONS 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 GLOBAL VETERINARY VACCINES MARKET OVERVIEW 27
4.2 APAC VETERINARY VACCINES MARKET, BY TECHNOLOGY AND REGION 28
4.3 POULTRY VETERINARY VACCINES MARKET, BY DISEASE 29
4.4 VETERINARY VACCINES MARKET, BY GEOGRAPHY 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
5.2.1 DRIVERS 31
5.2.1.1 Growth in livestock population and repeated outbreaks of livestock diseases 31
5.2.1.2 Increasing adoption of companion animals 31
5.2.1.3 Rising incidence of zoonotic diseases 33
5.2.1.4 Initiatives by various government agencies, animal associations, and leading players 33
5.2.1.5 Introduction of new types of vaccines 34
5.2.2 RESTRAINTS 34
5.2.2.1 High storage costs for vaccines 34
5.2.3 OPPORTUNITIES 35
5.2.3.1 Technological advancements 35
5.2.3.2 Growing awareness of animal health in emerging economies 35
5.2.4 CHALLENGE 36
5.2.4.1 Inadequate surveillance and reporting systems 36
6 VETERINARY VACCINES MARKET, BY TYPE 37
6.1 INTRODUCTION 38
6.2 PORCINE VACCINES 39
6.3 POULTRY VACCINES 41
6.4 LIVESTOCK VACCINES 42
6.4.1 BOVINE VACCINES 44
6.4.2 SMALL RUMINANT VACCINES 45
6.5 COMPANION ANIMAL VACCINES 46
6.5.1 CANINE VACCINES 48
6.5.2 FELINE VACCINES 49
6.6 AQUACULTURE VACCINES 51
6.7 OTHER ANIMAL VACCINES 52
7 VETERINARY VACCINES MARKET, BY DISEASE 53
7.1 INTRODUCTION 54
7.2 PORCINE 54
• PORCINE CIRCOVIRUS II
• PORCINE REPRODUCTIVE RESPIRATORY SYNDROME
• PORCINE PARVOVIRUS
• SWINE INFLUENZA
• SWINE PNEUMONIA
• OTHER PORCINE DISEASES
7.3 POULTRY 58
• INFECTIOUS BRONCHITIS
• AVIAN INFLUENZA
• NEWCASTLE DISEASE
• COCCIDIOSIS
• INFECTIOUS BURSAL DISEASE
• OTHER POULTRY DISEASES
7.4 LIVESTOCK 62
7.4.1 BOVINE 63
O FOOT-AND-MOUTH DISEASE
O BOVINE VIRAL DIARRHEA
O BOVINE CLOSTRIDIAL DISEASES
O BRUCELLOSIS
O INFECTIOUS BOVINE RHINOTRACHEITIS
O OTHER BOVINE DISEASES
7.4.2 SMALL RUMINANTS 65
O CLOSTRIDIAL DISEASE
O SCABBY MOUTH DISEASE
O PNEUMONIA AND SEPTICEMIA
O POX DISEASE
O OVINE JOHNE’S DISEASE
O OTHER SMALL RUMINANT DISEASES
7.5 COMPANION ANIMALS 66
7.5.1 CANINE 66
O CANINE RABIES
O CANINE DISTEMPER
O CANINE PARVOVIRUS
O OTHER CANINE DISEASES
7.5.2 FELINE 66
O FELINE RABIES
O FELINE VIRAL RHINOTRACHEITIS
O FELINE PANLEUKEMIA
O OTHER FELINE DISEASES
7.6 AQUACULTURE 67
• VIBRIOSIS
• PASTEURELLOSIS
• FURUNCULOSIS
• OTHER AQUACULTURE DISEASES
8 VETERINARY VACCINES MARKET, BY TECHNOLOGY 68
8.1 INTRODUCTION 69
8.2 LIVE ATTENUATED VACCINES 70
8.3 INACTIVATED VACCINES 71
8.4 TOXOID VACCINES 72
8.5 RECOMBINANT VACCINES 74
8.6 OTHER VACCINES 75
9 VETERINARY VACCINES MARKET, BY REGION 77
9.1 INTRODUCTION 78
9.2 EUROPE 79
9.3 NORTH AMERICA 83
9.3.1 US 87
9.3.2 CANADA 90
9.4 ASIA PACIFIC (APAC) 93
9.4.1 CHINA 98
9.4.2 THAILAND 101
9.4.3 INDIA 103
9.4.4 REST OF APAC 106
9.5 REST OF THE WORLD 109
10 COMPETITIVE LANDSCAPE 112
10.1 MARKET RANKING ANALYSIS 112
11 COMPANY PROFILES 113
(BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*
11.1 ZOETIS 113
11.2 MERCK ANIMAL HEALTH 116
11.3 BOEHRINGER INGELHEIM 119
11.4 ELANCO 122
11.5 CEVA 125
11.6 VIRBAC 128
11.7 VETOQUINOL 131
11.8 PHIBRO ANIMAL HEALTH 133
11.9 HESTER 136
11.10 HIPRA 138
11.11 IDT BIOLOGIKA 140
11.12 BIOGENESIS BAGO 142
11.13 TIANJIN RINGPU 143
11.14 CHINA ANIMAL HUSBANDRY 144
11.15 JINYU BIO-TECHNOLOGY 146
*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.
12 APPENDIX 147
LIST OF TABLES
TABLE 1 GLOBAL LIVESTOCK ANIMAL POPULATION, 2000 AND 2013 31
TABLE 2 ANIMAL DISEASE OUTBREAKS REPORTED IN RECENT YEARS 31
TABLE 3 PERCENTAGE OF PET OWNERSHIP, BY COUNTRY, 2016 32
TABLE 4 SMALL COMPANION ANIMAL POPULATION, BY COUNTRY, 2014 VS. 2016 (MILLION) 32
TABLE 5 VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 39
TABLE 6 PORCINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 40
TABLE 7 NORTH AMERICA: PORCINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 40
TABLE 8 ASIA PACIFIC: PORCINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 40
TABLE 9 POULTRY VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 41
TABLE 10 NORTH AMERICA: POULTRY VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 41
TABLE 11 ASIA PACIFIC: POULTRY VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 42
TABLE 12 LIVESTOCK VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 42
TABLE 13 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 43
TABLE 14 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 43
TABLE 15 LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 43
TABLE 16 BOVINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 44
TABLE 17 NORTH AMERICA: BOVINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 44
TABLE 18 ASIA PACIFIC: BOVINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 45
TABLE 19 SMALL RUMINANT VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 45
TABLE 20 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 46
TABLE 21 ASIA PACIFIC: SMALL RUMINANT VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 46
TABLE 22 COMPANION ANIMAL VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 47
TABLE 23 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 47
TABLE 24 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 47
TABLE 25 COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 48
TABLE 26 CANINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 48
TABLE 27 NORTH AMERICA: CANINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 49
TABLE 28 ASIA PACIFIC: CANINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 49
TABLE 29 FELINE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 30 NORTH AMERICA: FELINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 50
TABLE 31 ASIA PACIFIC: FELINE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 50
TABLE 32 AQUACULTURE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 33 NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 51
TABLE 34 OTHER ANIMAL VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 35 NORTH AMERICA: OTHER ANIMAL VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 52
TABLE 36 PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 54
TABLE 37 PORCINE CIRCOVIRUS II VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 55
TABLE 38 NORTH AMERICA: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 55
TABLE 39 ASIA PACIFIC: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 55
TABLE 40 PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET,
BY REGION, 2015–2022 (USD MILLION) 56
TABLE 41 NORTH AMERICA: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 42 ASIA PACIFIC: PORCINE REPRODUCTIVE RESPIRATORY SYNDROME VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 43 PORCINE PARVOVIRUS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 57
TABLE 44 NORTH AMERICA: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 45 ASIA PACIFIC: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 58
TABLE 46 POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 59
TABLE 47 INFECTIOUS BRONCHITIS VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 59
TABLE 48 NORTH AMERICA: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 59
TABLE 49 ASIA PACIFIC: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 60
TABLE 50 AVIAN INFLUENZA VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 51 NORTH AMERICA: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 61
TABLE 52 ASIA PACIFIC: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 61
TABLE 53 NEWCASTLE DISEASE VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 61
TABLE 54 NORTH AMERICA: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 62
TABLE 55 ASIA PACIFIC: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 62
TABLE 56 BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 63
TABLE 57 FOOT-AND-MOUTH DISEASE VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 63
TABLE 58 BOVINE VIRAL DIARRHEA VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 64
TABLE 59 BOVINE CLOSTRIDIAL DISEASE VACCINES MARKET, BY REGION,
2015–2022 (USD MILLION) 64
TABLE 60 BRUCELLOSIS VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 65
TABLE 61 SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 65
TABLE 62 CANINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 66
TABLE 63 FELINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 66
TABLE 64 AQUACULTURE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 67
TABLE 65 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 69
TABLE 66 LIVE ATTENUATED VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 70
TABLE 67 NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 70
TABLE 68 ASIA PACIFIC: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 71
TABLE 69 INACTIVATED VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 70 NORTH AMERICA: INACTIVATED VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 72
TABLE 71 ASIA PACIFIC: INACTIVATED VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 72
TABLE 72 TOXOID VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 73
TABLE 73 NORTH AMERICA: TOXOID VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 73
TABLE 74 ASIA PACIFIC: TOXOID VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 73
TABLE 75 RECOMBINANT VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 74
TABLE 76 NORTH AMERICA: RECOMBINANT VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 74
TABLE 77 ASIA PACIFIC: RECOMBINANT VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 75
TABLE 78 OTHER VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 75
TABLE 79 NORTH AMERICA: OTHER VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 76
TABLE 80 ASIA PACIFIC: OTHER VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 76
TABLE 81 VETERINARY VACCINES MARKET, BY REGION, 2015–2022 (USD MILLION) 78
TABLE 82 EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 83 EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 81
TABLE 84 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 81
TABLE 85 EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 82
TABLE 86 EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 82
TABLE 87 EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 83
TABLE 88 EUROPE: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 83
TABLE 89 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 84
TABLE 90 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 84
TABLE 91 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 85
TABLE 92 NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 85
TABLE 93 NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 85
TABLE 94 NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 86
TABLE 95 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 86
TABLE 96 NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 87
TABLE 97 US: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 88
TABLE 98 US: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 88
TABLE 99 US: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 88
TABLE 100 US: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 89
TABLE 101 US: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 89
TABLE 102 US: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 90
TABLE 103 CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 90
TABLE 104 CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 91
TABLE 105 CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 91
TABLE 106 CANADA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 91
TABLE 107 CANADA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 92
TABLE 108 CANADA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 92
TABLE 109 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 95
TABLE 110 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 95
TABLE 111 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 95
TABLE 112 ASIA PACIFIC: PORCINE VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 96
TABLE 113 ASIA PACIFIC: POULTRY VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 96
TABLE 114 ASIA PACIFIC: BOVINE VACCINES MARKET, BY DISEASE,
2015–2022 (USD MILLION) 97
TABLE 115 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 97
TABLE 116 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 98
TABLE 117 CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 98
TABLE 118 CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 99
TABLE 119 CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 99
TABLE 120 CHINA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 99
TABLE 121 CHINA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 100
TABLE 122 CHINA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 100
TABLE 123 THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 101
TABLE 124 THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 101
TABLE 125 THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 102
TABLE 126 THAILAND: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 102
TABLE 127 THAILAND: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 103
TABLE 128 THAILAND: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 103
TABLE 129 INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 104
TABLE 130 INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 104
TABLE 131 INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 104
TABLE 132 INDIA: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 105
TABLE 133 INDIA: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 105
TABLE 134 INDIA: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 106
TABLE 135 ROAPAC: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 106
TABLE 136 ROAPAC: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 107
TABLE 137 ROAPAC: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 107
TABLE 138 ROAPAC: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 107
TABLE 139 ROAPAC: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 108
TABLE 140 ROAPAC: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 108
TABLE 141 ROW: VETERINARY VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 109
TABLE 142 ROW: LIVESTOCK VACCINES MARKET, BY TYPE, 2015–2022 (USD MILLION) 109
TABLE 143 ROW: COMPANION ANIMAL VACCINES MARKET, BY TYPE,
2015–2022 (USD MILLION) 110
TABLE 144 ROW: PORCINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 110
TABLE 145 ROW: POULTRY VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 110
TABLE 146 ROW: BOVINE VACCINES MARKET, BY DISEASE, 2015–2022 (USD MILLION) 111
TABLE 147 ROW: VETERINARY VACCINES MARKET, BY TECHNOLOGY,
2015–2022 (USD MILLION) 111
TABLE 148 RANK OF COMPANIES IN THE VETERINARY VACCINES MARKET, 2017 112
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 19
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 21
FIGURE 5 DATA TRIANGULATION METHODOLOGY 22
FIGURE 6 VETERINARY VACCINES MARKET, BY TYPE, 2017 VS. 2022 24
FIGURE 7 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017 VS. 2022 25
FIGURE 8 PORCINE VACCINES MARKET, BY DISEASE, 2017 VS. 2022 25
FIGURE 9 VETERINARY VACCINES MARKET, BY REGION 26
FIGURE 10 GROWTH IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES ARE DRIVING THE VETERINARY VACCINES MARKET 27
FIGURE 11 LIVE ATTENUATED VACCINES SEGMENT IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2017 28
FIGURE 12 INFECTIOUS BRONCHITIS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017 AND 2022 29
FIGURE 13 APAC IS EXPECTED TO HAVE THE FASTEST CAGR DURING THE FORECAST PERIOD 29
FIGURE 14 VETERINARY VACCINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 30
FIGURE 15 PORCINE VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2017 38
FIGURE 16 LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2022 69
FIGURE 17 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD 78
FIGURE 18 EUROPE: VETERINARY VACCINES MARKET SNAPSHOT 80
FIGURE 19 ASIA PACIFIC: VETERINARY VACCINES MARKET SNAPSHOT 94
FIGURE 20 ZOETIS: COMPANY SNAPSHOT (2016) 113
FIGURE 21 MERCK & CO. INC.: COMPANY SNAPSHOT (2016) 116
FIGURE 22 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2016) 119
FIGURE 23 ELANCO: COMPANY SNAPSHOT (2016) 122
FIGURE 24 CEVA: COMPANY SNAPSHOT (2016) 125
FIGURE 25 VIRBAC: COMPANY SNAPSHOT (2016) 128
プレスリリース
プレスリリース
当レポートのプレスリリースは発行されておりません。
リサーチカテゴリ一覧
スマートグリッド
獣医画像診断の世界市場：2022年に至る製品タイプ別、診断領域別予測
お問合わせはこちらから
